More than 75% of breast tumors express the estrogen receptor (ER), and a review by Gérard et al. stated that current knowledge suggests that the association between obesity and postmenopausal breast cancer is highest among the hormone-receptor-positive cases [92]. The gene discussed is ESR1; the disease is obesity due to melanocortin 4 receptor deficiency.